AI assistant
Sending…
CONMED Corp — Director's Dealing 2019
Aug 6, 2019
31971_dirs_2019-08-06_43783b14-f1c4-4b68-9737-1134ce2ab8f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-08-02
Reporting Person: Pelletier Johonna Marie (Treasurer and VP, Tax)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-02 | Common Stock | M | 2000 | $51.30 | Acquired | 5665 | Direct |
| 2019-08-02 | Common Stock | F | 1547 | $92.38 | Disposed | 4118 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-02 | Sars (Stock Appreciation Rights) | $51.30 | M | 2000 | Disposed | 2025-02-27 | Common Stock (2000) | Direct |
Footnotes
F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7